Post-market surveillance, complaint handling, regulatory reporting support, and medical information services
Type of products covered: medical devices, therapeutic drugs, drug device combination products, SaMD.
Processes owned: Multilingual complaint intake and registration, coding, regulatory reporting, investigation coding, and closure of reportable and non-reportable complaints, across US, EMEA, LATAM, APAC and Canada.
Medical information: Medical and technical inquiries in multiple languages via voice and non-voice channels.
Client Background
The customer is a world leader in specialty oncology injectable, integrated infusion therapy, generic injectable pharmaceuticals, generic acute-care, and medication management solutions.
This US-based Company has global operations that develop, manufacture, and sell medical technologies used in vascular therapy, oncology, and critical care applications. Products are designed to prevent bloodstream infections and in protecting health care workers from exposure to infectious diseases or hazardous drugs. In addition, the company's IV medication compounding and delivery products are designed to improve medication, dosing accuracy, and clinical workflows.
Challenge
Solution
Implemented the following initiatives:
Business Impact
Tangible Benefit:
Intangible Benefits:
“This is a story of consistent growth, improved quality outcomes, consistent performance, flexible team, proven scalability, and a highly responsive team.”
A leading US-based health care services company refurbishes its contract lifecycle management system, leading to 100% visibility into contracts
By offering innovative solutions through robotics, artificial intelligence, analytics and digitization, the industry is gearing up for the next phase of its evolution - SSC 4.0
An American technology company realizes 40% productivity benefit and savings of USD 2 Million over 5 years by transferring shared services center ownership to Wipro.
